Promotes GH hypersecretion in GH-secreting pituitary tumors; it is positively correlated with GH and IGF1 serum levels; it is negatively correlated with tumor size. Gsp, an oncogene, could enhance MEG3 expression and may lead to GH hypersecretion. This evidence concerns the gene GNAS and neoplasm.